top of page

Top 20 Life Science Startups to Watch in 2019

  • maura169
  • Jan 7, 2019
  • 1 min read


 

BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017. 


The NextGen Bio Class of 2019 is a stellar group of companies that are already making an enormous impact on the industry now and will continue into the future. Congratulations to this group! 


Skyhawk Therapeutics 

Points: 17

Launched: 2018

Location: Waltham, MA 


Notable:

  • In June 2018, Skyhawk Therapeutics closed a $40 million equity investment round and then, in an unusual deal, signed a five-year collaborative agreement with Celgene that included an upfront $60 million.

  • Skyhawk focuses on developing small molecule therapeutics that correct RNA mis-splicing, what is usually called exon skipping.

  • The company expects to move its first oncology treatment into the clinic in 2019.

  • Skyhawk currently has four targets in oncology and three in neuro, which are in lead selection but past preclinical IND filing.




For more information visit:


SKYHAWK MEDIA CONTACT:

Maura McCarthy




 
 
 

Yorumlar


Small Molecules that Modify RNA Expression
Contact

Skyhawk Therapeutics, Inc.
180 3rd Ave., Fifth Floor
Waltham, MA 02451
United States

info@skyhawktx.com
1-617-858-0041

Skyhawk Therapeutics Europe, GmbH
Hochbergerstrasse 60I
Basel 4057 Switzerland
+41 (0) 61 512 15 20

Sitemap
  • X
  • LinkedIn

©2024 Skyhawk Therapeutics - All Rights Reserved

Skyhawk, SkyStar and triangle mark are federally registered trademarks owned by Skyhawk Therapeutics, Inc.

bottom of page